Here is how Agilent Technologies (A) and Concentra Group (CON) have performed compared to their sector so far this year.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its ...

BofASecurities analyst Michael Ryskin maintains $Agilent Technologies(A.US)$ with a buy rating, and adjusts the target price ...

As Q3 2026 earnings season approaches, healthcare stocks are drawing investor attention as markets assess earnings expectations across biotechnology, pharmaceuticals, healthcare services, medical ...

Agilent Technologies, Inc. specializes in the design, manufacturing and marketing of measurement instruments intended primarily for the communications, electronics, life sciences, and chemistry ...

Agilent Technologies has delivered a solid share price run over recent years, and the question now is whether the current ...

Learn more Agilent Technologies (A) has an average rating of overweight and mean price target of $179.61, according to analysts polled by FactSet.

Agilent Technologies has launched the NovoStation Sample Preparation System, an automated platform designed to cut manual ...

The new space complements established solid-phase synthesis operations, giving Agilent's Advanced Therapeutics Division a dedicated environment to develop solvent-free enzymatic manufacturing approach ...

The pharmaceutical services firm SK pharmteco said it will spend $200 million over the next 5 years to expand US capacity to ...

Follow Agilent Technologies, as investors assess operating repair and valuation discipline, the current catalyst, execution risks and the company evidence that may shape its next market move.